Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
Espen B. Ellingsen(Oslo University Hospital), Gustav Gaudernack(Oslo University Hospital), Sara M. Mangsbo(Uppsala University), Iliana Kerzeli(Uppsala University), Donjetë Simnica(University Hospital in Halle), Artur Mezheyeuski(Uppsala University), Gergana Bounova(The Netherlands Cancer Institute), Irantzu Anzar(Oslo Cancer Cluster), Tormod Kyrre Guren(Oslo University Hospital), Mascha Binder(Universität Hamburg), Eivind Hovig(Oslo University Hospital), Trevor Clancy(Inholland University of Applied Sciences), Else Marit Inderberg(Oslo University Hospital), Elin Aamdal(Oslo University Hospital)
Cited by 21
Related Papers
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
|Nature Communications|2015|337
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
|Clinical Cancer Research|2018|195